Abstract
In this study, Lactobacillus casei was used to deliver and express human lactoferrin (hLF) to protect the host against bacterial infection. Full-length hLF cDNA was cloned into a Lactobacillus-specific plasmid to produce the L. casei transformants (rhLF/L. casei). Antimicrobial activity of recombinant hLF was examined in inhibition of bacteria growth in vitro. A mouse model was established to test in vivo antibacterial activity and protective effect of orally-administered probiotic L. casei transformant in the gastrointestinal tract. Trials were conducted in which animals were challenged with E. coli ATCC25922. E. coli colony numbers in duodenal fluid from the group fed with rhLF/L. casei were significantly lower than those of the group fed with wild-type L. casei or placebo (P < 0.01). Histopathological analyses of the small intestine, showed both decreased intestinal injury and increased villi length were observed in the mice fed with rhLF/L. casei as compared with the control groups (P < 0.01). Our results demonstrate that L. casei expressing hLF exhibited antibacterial activity both in in vitro and in vivo. It also provides a potentially large-scale production of hLF as applications for treatment of infections caused by clinically relevant pathogens.
Similar content being viewed by others
References
Asahara T, Nomoto K, Watanuki M, Yokokura T (2001) Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection. Antimicrob Agents Chemother 45:1751–1760
Aso Y, Akaza H (1992) Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. Urol Int 49:125–129
Atkinson C, Song H, Lu B, Qiao F, Burns T, Holers VM, Tomlinson S (2005) Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection. J Clin Invest 115:2444–2453
Beljaars L, van der Strate BW, Bakker HI, Reker-Smit C, van Loenen-Weemaes AM, Wiegmans FC, Harmsen MC, Molema G, Meijer DK (2004) Inhibition of cytomegalovirus infection by lactoferrin in vitro and in vivo. Antiviral Res 63:197–208
Bhimani RS, Vendrov Y, Furmanski P (1999) Influence of lactoferrin feeding and injection against systemic staphylococcal infections in mice. J Appl Microbiol 86:135–144
Charng YC, Lin CC, Hsu CH (2006) Inhibition of allergen-induced airway inflammation and hyperreactivity by recombinant lactic-acid bacteria. Vaccine 24:5931–5936
Chen CM, Chen HL, Hsiau TH, Hsiau AHA, Shi H, Brock GJR, Wei SH, Caldwell CW, Yan PS, Huang THM (2003) Methylation target array for rapid analysis of CpG island hypermethylation in multiple tissue genome. Am J Pathol 163:37–45
Chen HL, Lai YW, Yen CC, Lin YY, Lu CY, Yang SH, Tsai TC, Lin YJ, Lin CW, Chen CM (2004) Production of recombinant porcine lactoferrin exhibiting antibacterial activity in methylotrophic yeast, Pichia pastoris. J Mol Microbiol Biotechnol 8:141–149
Chen HL, Yen CC, Tsai TC, Yu CH, Liou YJ, Lai YW, Wang ML, Chen CM (2006a) Production and characterization of human extracellular superoxide dismutase (ECSOD) in methylotrophic yeast, Pichia pastoris. J Agric Food Chem 54:8041–8047
Chen HL, Yen CC, Lu CY, Yu CH, Chen CM (2006b) Synthetic porcine lactoferricin with a 20-residue peptide exhibits antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Candida albicans. J Agric Food Chem 54:3277–3282
Chen HL, Huang JY, Chu TW, Tsai TC, Hung CM, Lin CC, Liu FC, Wang LC, Chen YJ, Lin MF, Chen CM (2008a) Expression of VP1 protein in the milk of transgenic mice: as a potential oral vaccine against for enterovirus 71 strain infection. Vaccine 26:2882–2889
Chen HL, Wang LC, Chang CH, Yen CC, Cheng WTK, Wu SC, Hung CM, Kuo MF, Chen CM (2008b) Recombinant porcine lactoferrin expressed in the milk of transgenic mice protects neonatal mice from a lethal challenge with enterovirus type 71. Vaccine 26:891–898
Chouraqui JP, Grathwohl D, Labaune JM, Hascoet JM, de Montgolfier I, Leclaire M, Giarre M, Steenhout P (2008) Assessment of the safety, tolerance, and protective effect against diarrhea of infant formulas containing mixtures of probiotics or probiotics and prebiotics in a randomized controlled trial. Am J Clin Nutr 87:1365–1373
Dogi CA, Galdeano CM, Perdigon G (2008) Gut immune stimulation by non pathogenic Gram(+) and Gram(-) bacteria: comparison with a probiotic strain. Cytokine 41:223–231
Drobni P, Naslund J, Evander M (2004) Lactoferrin inhibits human papillomavirus binding and uptake in vitro. Antiviral Res 64:63–68
Edde L, Hipolito RB, Hwang FFY, Headon DR, Shalwitz RA, Sherman MP (2001) Lactoferrin protects neonatal rats from gut-related systemic infection. Am J Physiol Gastrointest Liver Physiol 281:1140–1150
Geoffroy MC, Guyard C, Quatannens B, Pavan S, Lange M, Mercenier A (2000) Use of green fluorescent protein to tag lactic acid bacterium strains under development as live vaccine vectors. Appl Environ Microbiol 66:383–391
Hose H, Sozzi T (1991) Probiotics, fact or fiction. J Chem Technol Biotech 51:540–544
Humphrey BD, Huang N, Klasing KC (2002) Rice expressing lactoferrin and lysozyme has antibiotic-like properties when fed to chicks. J Nutr 132:1214–1218
Kekkonen RA, Sysi-Aho M, Seppanen-Laakso T, Julkunen I, Vapaatalo H, Oresic M, Korpela R (2008) Effect of probiotic Lactobacillus rhamnosus GG intervention on global serum lipidomic profiles in healthy adults. World J Gastroenterol 14:3188–3194
Legrand D, Elass E, Pierce A, Mazurier J (2004) Lactoferrin and host defence: an overview of its immuno-modulating and anti-inflammatory properties. Biometals 17:225–229
Lonnerdal B, Iyer S (1995) Lactoferrin: molecular structure and biological function. Annu Rev Nutr 15:93–110
Meyer-Hoffert U, Hornef MW, Henriques-Normark B, Axelsson LG, Midtvedt T, Pütsep K, Andersson M (2008) Secreted enteric antimicrobial activity localises to the mucus surface layer. Gut 57:764–771
Morteau O, Morham SG, Sellon R, Dieleman LA, Langenbach R, Smithies O, Sartor RB (2000) Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2. J Clin Invest 105:469–478
Nakajima A, Wada K, Miki H, Kubota N, Nakajima N, Terauchi Y, Ohnishi S, Saubermann LJ, Kadowaki T, Blumaerg RS, Nagai R, Matsuhashi N (2001) Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury. Gastroenterology 120:460–469
Oh SM, Pyo CW, Kim Y, Choi SY (2004) Neutrophil lactoferrin upregulates the human p53 gene through induction of NF-kappaB activation cascade. Oncogene 23:8282–8291
Paturi G, Phillips M, Kailasapathy K (2008) Effect of probiotic strains Lactobacillus acidophilus LAFTI L10 and Lactobacillus paracasei LAFTI L26 on systemic immune functions and bacterial translocation in mice. J Food Prot 71:796–801
Posno M, Heuvelmans PT, van Giezen MJ, Lokman BC, Leer RJ, Pouwels PH (1991) Complementation of the inability of Lactobacillus strains to utilize d-xylose with d-xylose catabolism-encoding genes of Lactobacillus pentosus. Appl Environ Microbiol 57:2764–2766
Pouwels PH, Leer RJ, Boersma WJ (1996) The potential of Lactobacillus as a carrier for oral immunization: Development and preliminary characterization of vector systems for targeted delivery of antigens. J Biotechnol 44:183–192
Salmon V, Legrand D, Georges B, Slomianny MC, Coddeville B, Spik G (1997) Characterization of human lactoferrin produced in the baculovirus expression system. Protein Expr Purif 9:203–210
Saunier K, Dore J (2002) Gastrointestinal tract and the elderly: functional foods, gut microflora and healthy ageing. Dig Liver Dis 2:S19–S24
Seegers JF (2002) Lactobacilli as live vaccine delivery vectors: progress and prospects. Trends Biotechnol 20:508–515
Sfeir RM, Dubarry M, Boyaka PN, Rautureau M, Tome D (2004) The mode of oral bovine lactoferrin administration influences mucosal and systemic immune responses in mice. J Nutr 134:403–409
Sgouras D, Maragkoudakis P, Petraki K, Martinez-Gonzalez B, Eriotou E, Michopoulos S, Kalantzopoulos G, Tsakalidou E, Mentis A (2004) In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl Environ Microbiol 70:518–526
Sherman MP, Bennett SH, Hwang FF, Yu C (2004) Neonatal small bowel epithelia: enhancing anti-bacterial defense with lactoferrin and Lactobacillus GG. Biometals 17:285–289
Takeuchi T, Kitagawa H, Harada E (2004) Evidence of lactoferrin transportation into blood circulation from intestine via lymphatic pathway in adult rats. Exp Physiol 89:263–270
Teraguchi S, Wakabayashi H, Kuwata H, Yamauchi K, Tamura Y (2004) Protection against infections by oral lactoferrin: evaluation in animal models. Biometals 17:231–234
Tomita M, Wakabayashi H, Yamauchi K, Teraguchi S, Hayasawa H (2002) Bovine lactoferrin and lactoferricin derived from milk: production and applications. Biochem Cell Biol 80:109–112
Van Berkel PH, Welling MM, Geerts M, van Veen HA, Ravensbergen B, Salaheddine M, Pauwels EK, Pieper F, Nuijens JH, Nibbering PH (2002) Large scale production of recombinant human lactoferrin in the milk of transgenic cows. Nat Biotechnol 20:484–487
Wanker E, Leer RJ, Pouwels PH, Schwab H (1995) Expression of Bacillus subtilis levanase gene in Lactobacillus plantarum and Lactobacillus casei. Appl Microbiol Biotechnol 43:297–303
Ward PP, Paz E, Conneely OM (2005) Multifunctional roles of lactoferrin: a critical overview. Cell Mol Life Sci 62:2540–2548
Wu SC, Chen HL, Yen CC, Kuo MF, Yang TS, Wang SR, Weng CN, Chen CM, Cheng WTK (2007) Recombinant porcine lactoferrin expressed in the milk of transgenic mice enhances offspring growth performance. J Agric Food Chem 55:4670–4677
Yasui H, Kiyoshima J, Hori T (2004) Reduction of influenza virus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota. Clin Diagn Lab Immunol 11:675–679
Yen CC, Lin CY, Chong KY, Tsai TC, Shen CJ, Lin MF, Su CY, Chen HL, Chen CM (2009) Lactoferrin as a natural regimen of selective decontamination of the digestive tract: recombinant porcine lactoferrin expressed in the milk of transgenic mice protects neonates from pathogen challenges in the gastrointestinal tract. J Infect Dis 199:590–598
Zimecki M, Artym J, Chodaczek G, Kocieba M, Kruzel ML (2004) Protective effects of lactoferrin in Escherichia coli-induced bacteremia in mice: relationship to reduced serum TNF alpha level and increased turnover of neutrophils. Inflamm Res 53:292–296
Acknowledgments
The authors would like to thank Dr. Jeffrey Conrad for critically reading the manuscript. We also thank Mr. Tung-Chou Tsai for his assistance in animal care. This research was supported in part by grant NSC-96-2313-B- 005-012 from the National Science Council, and the Ministry of Education, Taiwan, Republic of China, under the ATU plan.
Author information
Authors and Affiliations
Corresponding author
Additional information
Hsiao-Ling Chen, Yi-Wen Lai, and Chua-Shun Chen contributed equally to this work.
Rights and permissions
About this article
Cite this article
Chen, HL., Lai, YW., Chen, CS. et al. Probiotic Lactobacillus casei Expressing Human Lactoferrin Elevates Antibacterial Activity in the Gastrointestinal Tract. Biometals 23, 543–554 (2010). https://doi.org/10.1007/s10534-010-9298-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10534-010-9298-0